financetom
Business
financetom
/
Business
/
US FDA approves J&J's combination therapy for type of lung cancer
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
US FDA approves J&J's combination therapy for type of lung cancer
Aug 20, 2024 4:21 AM

Aug 20 (Reuters) - The U.S. Food and Drug Administration

on Tuesday approved Johnson & Johnson's ( JNJ )

chemotherapy-free combination therapy for patients with a type

of non-small cell lung cancer.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved